Report Cover

Global Genetic Modification Therapies Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The Genetic Modification Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Genetic Modification Therapies size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Genetic Modification Therapies market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Genetic Modification Therapies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Gene Therapies
    Genetically Modified Cell Therapies
    RNA Therapies
    Gene Editing

Market segment by Application, can be divided into
    Hospitals
    Diagnostics and Testing Laboratories
    Academic and Research Organizations
    Others

Market segment by players, this report covers
    4D Molecular Therapeutics
    Abeona Therapeutics
    Allergan
    American Gene Technologies
    Merck Millipore
    AbbVie

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of Genetic Modification Therapies
    1.2 Classification of Genetic Modification Therapies by Type
        1.2.1 Overview: Global Genetic Modification Therapies Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Genetic Modification Therapies Revenue Market Share by Type in 2020
        1.2.3 Gene Therapies
        1.2.4 Genetically Modified Cell Therapies
        1.2.5 RNA Therapies
        1.2.6 Gene Editing
    1.3 Global Genetic Modification Therapies Market by Application
        1.3.1 Overview: Global Genetic Modification Therapies Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Diagnostics and Testing Laboratories
        1.3.4 Academic and Research Organizations
        1.3.5 Others
    1.4 Global Genetic Modification Therapies Market Size & Forecast
    1.5 Global Genetic Modification Therapies Market Size and Forecast by Region
        1.5.1 Global Genetic Modification Therapies Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Genetic Modification Therapies Market Size by Region, (2016-2021)
        1.5.3 North America Genetic Modification Therapies Market Size and Prospect (2016-2026)
        1.5.4 Europe Genetic Modification Therapies Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Genetic Modification Therapies Market Size and Prospect (2016-2026)
        1.5.6 South America Genetic Modification Therapies Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Genetic Modification Therapies Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Genetic Modification Therapies Market Drivers
        1.6.2 Genetic Modification Therapies Market Restraints
        1.6.3 Genetic Modification Therapies Trends Analysis
2 Company Profiles
    2.1 4D Molecular Therapeutics
        2.1.1 4D Molecular Therapeutics Details
        2.1.2 4D Molecular Therapeutics Major Business
        2.1.3 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions
        2.1.4 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 4D Molecular Therapeutics Recent Developments and Future Plans
    2.2 Abeona Therapeutics
        2.2.1 Abeona Therapeutics Details
        2.2.2 Abeona Therapeutics Major Business
        2.2.3 Abeona Therapeutics Genetic Modification Therapies Product and Solutions
        2.2.4 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Abeona Therapeutics Recent Developments and Future Plans
    2.3 Allergan
        2.3.1 Allergan Details
        2.3.2 Allergan Major Business
        2.3.3 Allergan Genetic Modification Therapies Product and Solutions
        2.3.4 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Allergan Recent Developments and Future Plans
    2.4 American Gene Technologies
        2.4.1 American Gene Technologies Details
        2.4.2 American Gene Technologies Major Business
        2.4.3 American Gene Technologies Genetic Modification Therapies Product and Solutions
        2.4.4 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 American Gene Technologies Recent Developments and Future Plans
    2.5 Merck Millipore
        2.5.1 Merck Millipore Details
        2.5.2 Merck Millipore Major Business
        2.5.3 Merck Millipore Genetic Modification Therapies Product and Solutions
        2.5.4 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Merck Millipore Recent Developments and Future Plans
    2.6 AbbVie
        2.6.1 AbbVie Details
        2.6.2 AbbVie Major Business
        2.6.3 AbbVie Genetic Modification Therapies Product and Solutions
        2.6.4 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 AbbVie Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Genetic Modification Therapies Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Genetic Modification Therapies Players Market Share
        3.2.2 Top 10 Genetic Modification Therapies Players Market Share
        3.2.3 Market Competition Trend
    3.3 Genetic Modification Therapies Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Genetic Modification Therapies Revenue and Market Share by Type (2016-2021)
    4.2 Global Genetic Modification Therapies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Genetic Modification Therapies Revenue Market Share by Application (2016-2021)
    5.2 Genetic Modification Therapies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Genetic Modification Therapies Revenue by Type (2016-2026)
    6.2 North America Genetic Modification Therapies Revenue by Application (2016-2026)
    6.3 North America Genetic Modification Therapies Market Size by Country
        6.3.1 North America Genetic Modification Therapies Revenue by Country (2016-2026)
        6.3.2 United States Genetic Modification Therapies Market Size and Forecast (2016-2026)
        6.3.3 Canada Genetic Modification Therapies Market Size and Forecast (2016-2026)
        6.3.4 Mexico Genetic Modification Therapies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Genetic Modification Therapies Revenue by Type (2016-2026)
    7.2 Europe Genetic Modification Therapies Revenue by Application (2016-2026)
    7.3 Europe Genetic Modification Therapies Market Size by Country
        7.3.1 Europe Genetic Modification Therapies Revenue by Country (2016-2026)
        7.3.2 Germany Genetic Modification Therapies Market Size and Forecast (2016-2026)
        7.3.3 France Genetic Modification Therapies Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Genetic Modification Therapies Market Size and Forecast (2016-2026)
        7.3.5 Russia Genetic Modification Therapies Market Size and Forecast (2016-2026)
        7.3.6 Italy Genetic Modification Therapies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Genetic Modification Therapies Revenue by Type (2016-2026)
    8.2 Asia-Pacific Genetic Modification Therapies Revenue by Application (2016-2026)
    8.3 Asia-Pacific Genetic Modification Therapies Market Size by Region
        8.3.1 Asia-Pacific Genetic Modification Therapies Revenue by Region (2016-2026)
        8.3.2 China Genetic Modification Therapies Market Size and Forecast (2016-2026)
        8.3.3 Japan Genetic Modification Therapies Market Size and Forecast (2016-2026)
        8.3.4 South Korea Genetic Modification Therapies Market Size and Forecast (2016-2026)
        8.3.5 India Genetic Modification Therapies Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Genetic Modification Therapies Market Size and Forecast (2016-2026)
        8.3.7 Australia Genetic Modification Therapies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Genetic Modification Therapies Revenue by Type (2016-2026)
    9.2 South America Genetic Modification Therapies Revenue by Application (2016-2026)
    9.3 South America Genetic Modification Therapies Market Size by Country
        9.3.1 South America Genetic Modification Therapies Revenue by Country (2016-2026)
        9.3.2 Brazil Genetic Modification Therapies Market Size and Forecast (2016-2026)
        9.3.3 Argentina Genetic Modification Therapies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Genetic Modification Therapies Revenue by Type (2016-2026)
    10.2 Middle East & Africa Genetic Modification Therapies Revenue by Application (2016-2026)
    10.3 Middle East & Africa Genetic Modification Therapies Market Size by Country
        10.3.1 Middle East & Africa Genetic Modification Therapies Revenue by Country (2016-2026)
        10.3.2 Turkey Genetic Modification Therapies Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Genetic Modification Therapies Market Size and Forecast (2016-2026)
        10.3.4 UAE Genetic Modification Therapies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Genetic Modification Therapies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global Genetic Modification Therapies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market Genetic Modification Therapies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global Genetic Modification Therapies Revenue (USD Million) by Region (2016-2021) Table 5. Global Genetic Modification Therapies Revenue Market Share by Region (2021-2026) Table 6. 4D Molecular Therapeutics Corporate Information, Head Office, and Major Competitors Table 7. 4D Molecular Therapeutics Major Business Table 8. 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions Table 9. 4D Molecular Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Abeona Therapeutics Corporate Information, Head Office, and Major Competitors Table 11. Abeona Therapeutics Major Business Table 12. Abeona Therapeutics Genetic Modification Therapies Product and Solutions Table 13. Abeona Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Allergan Corporate Information, Head Office, and Major Competitors Table 15. Allergan Major Business Table 16. Allergan Genetic Modification Therapies Product and Solutions Table 17. Allergan Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. American Gene Technologies Corporate Information, Head Office, and Major Competitors Table 19. American Gene Technologies Major Business Table 20. American Gene Technologies Genetic Modification Therapies Product and Solutions Table 21. American Gene Technologies Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. Merck Millipore Corporate Information, Head Office, and Major Competitors Table 23. Merck Millipore Major Business Table 24. Merck Millipore Genetic Modification Therapies Product and Solutions Table 25. Merck Millipore Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. AbbVie Corporate Information, Head Office, and Major Competitors Table 27. AbbVie Major Business Table 28. AbbVie Genetic Modification Therapies Product and Solutions Table 29. AbbVie Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. Global Genetic Modification Therapies Revenue (USD Million) by Players (2019-2021) Table 31. Global Genetic Modification Therapies Revenue Share by Players (2019-2021) Table 32. Breakdown of Genetic Modification Therapies by Company Type (Tier 1, Tier 2 and Tier 3) Table 33. Genetic Modification Therapies Players Head Office, Products and Services Provided Table 34. Genetic Modification Therapies Mergers & Acquisitions in the Past Five Years Table 35. Genetic Modification Therapies New Entrants and Expansion Plans Table 36. Global Genetic Modification Therapies Revenue (USD Million) by Type (2016-2021) Table 37. Global Genetic Modification Therapies Revenue Share by Type (2016-2021) Table 38. Global Genetic Modification Therapies Revenue Forecast by Type (2021-2026) Table 39. Global Genetic Modification Therapies Revenue by Application (2016-2021) Table 40. Global Genetic Modification Therapies Revenue Forecast by Application (2021-2026) Table 41. North America Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million) Table 42. North America Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million) Table 43. North America Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million) Table 44. North America Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million) Table 45. North America Genetic Modification Therapies Revenue by Country (2016-2021) & (USD Million) Table 46. North America Genetic Modification Therapies Revenue by Country (2021-2026) & (USD Million) Table 47. Europe Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million) Table 48. Europe Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million) Table 49. Europe Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million) Table 50. Europe Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million) Table 51. Europe Genetic Modification Therapies Revenue by Country (2016-2021) & (USD Million) Table 52. Europe Genetic Modification Therapies Revenue by Country (2021-2026) & (USD Million) Table 53. Asia-Pacific Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million) Table 54. Asia-Pacific Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million) Table 55. Asia-Pacific Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million) Table 56. Asia-Pacific Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million) Table 57. Asia-Pacific Genetic Modification Therapies Revenue by Region (2016-2021) & (USD Million) Table 58. Asia-Pacific Genetic Modification Therapies Revenue by Region (2021-2026) & (USD Million) Table 59. South America Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million) Table 60. South America Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million) Table 61. South America Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million) Table 62. South America Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million) Table 63. South America Genetic Modification Therapies Revenue by Country (2016-2021) & (USD Million) Table 64. South America Genetic Modification Therapies Revenue by Country (2021-2026) & (USD Million) Table 65. Middle East & Africa Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million) Table 66. Middle East & Africa Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million) Table 67. Middle East & Africa Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million) Table 68. Middle East & Africa Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million) Table 69. Middle East & Africa Genetic Modification Therapies Revenue by Country (2016-2021) & (USD Million) Table 70. Middle East & Africa Genetic Modification Therapies Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. Genetic Modification Therapies Picture Figure 2. Global Genetic Modification Therapies Revenue Market Share by Type in 2020 Figure 3. Gene Therapies Figure 4. Genetically Modified Cell Therapies Figure 5. RNA Therapies Figure 6. Gene Editing Figure 7. Genetic Modification Therapies Revenue Market Share by Application in 2020 Figure 8. Hospitals Picture Figure 9. Diagnostics and Testing Laboratories Picture Figure 10. Academic and Research Organizations Picture Figure 11. Others Picture Figure 12. Global Genetic Modification Therapies Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 13. Global Genetic Modification Therapies Revenue and Forecast (2016-2026) & (USD Million) Figure 14. Global Genetic Modification Therapies Revenue Market Share by Region (2016-2026) Figure 15. Global Genetic Modification Therapies Revenue Market Share by Region in 2020 Figure 16. North America Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. Europe Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026) Figure 18. Asia-Pacific Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026) Figure 19. South America Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026) Figure 20. Genetic Modification Therapies Market Drivers Figure 21. Genetic Modification Therapies Market Restraints Figure 22. Genetic Modification Therapies Market Trends Figure 23. 4D Molecular Therapeutics Recent Developments and Future Plans Figure 24. Abeona Therapeutics Recent Developments and Future Plans Figure 25. Allergan Recent Developments and Future Plans Figure 26. American Gene Technologies Recent Developments and Future Plans Figure 27. Merck Millipore Recent Developments and Future Plans Figure 28. AbbVie Recent Developments and Future Plans Figure 30. Global Genetic Modification Therapies Revenue Share by Players in 2020 Figure 31. Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 32. Global Top 3 Players Genetic Modification Therapies Revenue Market Share in 2020 Figure 33. Global Top 10 Players Genetic Modification Therapies Revenue Market Share in 2020 Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 35. Global Genetic Modification Therapies Revenue Share by Type in 2020 Figure 36. Global Genetic Modification Therapies Market Share Forecast by Type (2021-2026) Figure 37. Global Genetic Modification Therapies Revenue Share by Application in 2020 Figure 38. Global Genetic Modification Therapies Market Share Forecast by Application (2021-2026) Figure 39. North America Genetic Modification Therapies Sales Market Share by Type (2016-2026) Figure 40. North America Genetic Modification Therapies Sales Market Share by Application (2016-2026) Figure 41. North America Genetic Modification Therapies Revenue Market Share by Country (2016-2026) Figure 42. United States Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 43. Canada Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 44. Mexico Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 45. Europe Genetic Modification Therapies Sales Market Share by Type (2016-2026) Figure 46. Europe Genetic Modification Therapies Sales Market Share by Application (2016-2026) Figure 47. Europe Genetic Modification Therapies Revenue Market Share by Country (2016-2026) Figure 48. Germany Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 49. France Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 50. United Kingdom Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 51. Russia Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 52. Italy Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 53. Asia-Pacific Genetic Modification Therapies Sales Market Share by Type (2016-2026) Figure 54. Asia-Pacific Genetic Modification Therapies Sales Market Share by Application (2016-2026) Figure 55. Asia-Pacific Genetic Modification Therapies Revenue Market Share by Region (2016-2026) Figure 56. China Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 57. Japan Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. South Korea Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 59. India Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 60. Southeast Asia Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 61. Australia Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 62. South America Genetic Modification Therapies Sales Market Share by Type (2016-2026) Figure 63. South America Genetic Modification Therapies Sales Market Share by Application (2016-2026) Figure 64. South America Genetic Modification Therapies Revenue Market Share by Country (2016-2026) Figure 65. Brazil Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. Argentina Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 67. Middle East and Africa Genetic Modification Therapies Sales Market Share by Type (2016-2026) Figure 68. Middle East and Africa Genetic Modification Therapies Sales Market Share by Application (2016-2026) Figure 69. Middle East and Africa Genetic Modification Therapies Revenue Market Share by Country (2016-2026) Figure 70. Turkey Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. Saudi Arabia Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. UAE Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million) Figure 73. Methodology Figure 74. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us